Dannel Diaz Ruiz
Endocrinology, Diabetes & Metabolism · Mayaguez,, PRNPI 1679066435
Payments from drug & device makers
Across 75 payments — averaging $35.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$788
- Lilly USA, LLC$323
- E.r. Squibb & Sons, L.L.C.$287
- EMD Serono, Inc.$161
- Boehringer Ingelheim$125
- Novo Nordisk$125
- plus $851 from 14 others
What the payments were for
- Food & beverage$2,660100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 26 | $788 |
| Lilly USA, LLC | 11 | $323 |
| E.r. Squibb & Sons, L.L.C. | 8 | $287 |
| EMD Serono, Inc. | 2 | $161 |
| Boehringer Ingelheim | 1 | $125 |
| Novo Nordisk | 1 | $125 |
| Dexcom, Inc. | 1 | $121 |
| Madrigal Pharmaceuticals | 1 | $118 |
| BETA Bionics, Inc. | 1 | $116 |
| Radius Health, Inc. | 6 | $104 |
| Rhythm Pharmaceuticals, Inc. | 1 | $75 |
| Ultragenyx Pharmaceutical Inc. | 3 | $74 |
| PBG Puerto Rico LLC | 4 | $64 |
| Kyowa Kirin, Inc. | 2 | $41 |
| Medtronic | 2 | $37 |
| Johnson & Johnson | 1 | $24 |
| Corcept Therapeutics | 1 | $22 |
| Amryt Pharma Holdings Ltd | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Chiesi USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,660 in reported general payments places this provider in the 30th percentile of 143 endocrinology, diabetes & metabolism providers in Puerto Rico.
See all endocrinology, diabetes & metabolism providers in Puerto Rico →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 145 | $169,200 |
| TrulicityDulaglutide | 79 | $85,858 |
| JardianceEmpagliflozin | 111 | $83,213 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 50 | $33,301 |
| MounjaroTirzepatide | 28 | $30,187 |
| TradjentaLinagliptin | 42 | $22,330 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 27 | $15,757 |
| Xigduo XrDapaglifloz Propaned/Metformin | 17 | $12,908 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 115 | $11,786 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 58 | $9,435 |
| FarxigaDapagliflozin Propanediol | 13 | $8,753 |
| Novolog FlexpenInsulin Aspart | 21 | $5,626 |
| SynthroidLevothyroxine Sodium | 82 | $4,260 |
| HumalogInsulin Lispro | 15 | $1,924 |
| Pen NeedlePen Needle, Diabetic | 75 | $1,233 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $125 | $169,200145 claims |
| Boehringer IngelheimJardiance, Trijardy Xr, Tradjenta, Synjardy Xr | $125 | $154,602230 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog, Insulin Lispro | $323 | $119,189151 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 143 endocrinology, diabetes & metabolism providers in Puerto Rico.
Other endocrinology, diabetes & metabolism in Mayaguez,
- Angel Comulada RiveraBayamon$8.9M
- Ramon Ortiz CarrasquilloManati$6M
- Alex Gonzalez BossoloSan Juan$5.5M
- Martha GomezSan Juan$3.8M
- Paola Mansilla-LetelierBayamon$3.1M
- Altagracia Alcantara GonzalezBayamon$1M
- Myriam Allende-VigoHumacao$963K
- Jose Garcia MateoPonce$945K
- Wilfredo BravoCaguas$767K
- Michelle Mangual GarciaSan Juan$743K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.